These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

738 related articles for article (PubMed ID: 24316488)

  • 1. A genetic variant in p63 (rs17506395) is associated with breast cancer susceptibility and prognosis.
    Zhang N; Huo Q; Wang X; Chen X; Long L; Guan X; Jiang L; Ma T; Hu W; Yang Q
    Gene; 2014 Feb; 535(2):170-6. PubMed ID: 24316488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The TP63 Gene Polymorphism rs17506395 is Associated with Early Breast Cancer in Cameroon.
    Tiofack ATZ; Simo G; Ofon E; Dina-Bell E; Kamla CM; Ananga SN; Roger T; Nana TN; Ngeufack CT; Fewou A; Takongmo S; Lueong S
    Asian Pac J Cancer Prev; 2020 Aug; 21(8):2199-2208. PubMed ID: 32856845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MDR1 C3435T polymorphism in patients with breast cancer.
    Turgut S; Yaren A; Kursunluoglu R; Turgut G
    Arch Med Res; 2007 Jul; 38(5):539-44. PubMed ID: 17560460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of breast cancer susceptibility loci with patient characteristics, metastasis-free survival, and mRNA expression of the nearest genes.
    Riaz M; Berns EM; Sieuwerts AM; Ruigrok-Ritstier K; de Weerd V; Groenewoud A; Uitterlinden AG; Look MP; Klijn JG; Sleijfer S; Foekens JA; Martens JW
    Breast Cancer Res Treat; 2012 Jun; 133(3):843-51. PubMed ID: 21748294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic polymorphism of miR-196a as a prognostic biomarker for early breast cancer.
    Lee SJ; Seo JW; Chae YS; Kim JG; Kang BW; Kim WW; Jung JH; Park HY; Jeong JY; Park JY
    Anticancer Res; 2014 Jun; 34(6):2943-9. PubMed ID: 24922658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Association between single nucleotide polymorphisms of BARD 1 gene and susceptibility of early-onset breast cancer in Uygur women in Xinjiang].
    Sun G; Wang JT; Ma BL; Geng ZL; Ren GH; Shan MH; Ma B; Ma LL; Wang Y
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):341-7. PubMed ID: 22883453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant survival impact of MACC1 polymorphisms in HER2 positive breast cancer patients.
    Muendlein A; Hubalek M; Geller-Rhomberg S; Gasser K; Winder T; Drexel H; Decker T; Mueller-Holzner E; Chamson M; Marth C; Lang AH
    Eur J Cancer; 2014 Aug; 50(12):2134-41. PubMed ID: 24910416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single nucleotide polymorphisms of the aromatase gene (CYP19A1), HER2/neu status, and prognosis in breast cancer patients.
    Fasching PA; Loehberg CR; Strissel PL; Lux MP; Bani MR; Schrauder M; Geiler S; Ringleff K; Oeser S; Weihbrecht S; Schulz-Wendtland R; Hartmann A; Beckmann MW; Strick R
    Breast Cancer Res Treat; 2008 Nov; 112(1):89-98. PubMed ID: 18049890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of polymorphisms in circadian pathway genes in breast tumorigenesis.
    Dai H; Zhang L; Cao M; Song F; Zheng H; Zhu X; Wei Q; Zhang W; Chen K
    Breast Cancer Res Treat; 2011 Jun; 127(2):531-40. PubMed ID: 20978934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of heparanase gene (HPSE-1) single nucleotide polymorphisms with gastric cancer.
    Yue Z; Song Y; Wang Z; Luo Y; Jiang L; Xing L; Xu H; Zhang X
    J Surg Oncol; 2010 Jul; 102(1):68-72. PubMed ID: 20578081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADRA2A Germline Gene Polymorphism is Associated to the Severity, but not to the Risk, of Breast Cancer.
    Kaabi B; Belaaloui G; Benbrahim W; Hamizi K; Sadelaoud M; Toumi W; Bounecer H
    Pathol Oncol Res; 2016 Apr; 22(2):357-65. PubMed ID: 26563278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endostatin gene variation and protein levels in breast cancer susceptibility and severity.
    Balasubramanian SP; Cross SS; Globe J; Cox A; Brown NJ; Reed MW
    BMC Cancer; 2007 Jun; 7():107. PubMed ID: 17587451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine gene polymorphisms and breast cancer susceptibility and prognosis.
    Smith KC; Bateman AC; Fussell HM; Howell WM
    Eur J Immunogenet; 2004 Aug; 31(4):167-73. PubMed ID: 15265021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HER2 Codon 655 (Ile/Val) Polymorphism and Breast Cancer in Austrian Women.
    Watrowski R; Castillo-Tong DC; Wolf A; Schuster E; Fischer MB; Speiser P; Zeillinger R
    Anticancer Res; 2015 Nov; 35(11):5901-4. PubMed ID: 26504013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
    Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
    Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms in the KDR and POSTN genes: association with breast cancer susceptibility and prognosis.
    Försti A; Jin Q; Altieri A; Johansson R; Wagner K; Enquist K; Grzybowska E; Pamula J; Pekala W; Hallmans G; Lenner P; Hemminki K
    Breast Cancer Res Treat; 2007 Jan; 101(1):83-93. PubMed ID: 16807673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LFA-1 gene polymorphisms are associated with the sporadic infiltrative duct breast carcinoma in Chinese Han women of Heilongjiang Province.
    Fu Z; Jiao M; Zhang M; Xu F; Yuan W; Pang D; Li D
    Breast Cancer Res Treat; 2011 May; 127(1):265-71. PubMed ID: 20953905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes.
    Curtit E; Pivot X; Henriques J; Paget-Bailly S; Fumoleau P; Rios M; Bonnefoi H; Bachelot T; Soulié P; Jouannaud C; Bourgeois H; Petit T; Tennevet I; Assouline D; Mathieu MC; Jacquin JP; Lavau-Denes S; Darut-Jouve A; Ferrero JM; Tarpin C; Lévy C; Delecroix V; Trillet-Lenoir V; Cojocarasu O; Meunier J; Pierga JY; Kerbrat P; Faure-Mercier C; Blanché H; Sahbatou M; Boland A; Bacq D; Besse C; Thomas G; Deleuze JF; Pauporté I; Romieu G; Cox DG
    Breast Cancer Res; 2017 Aug; 19(1):98. PubMed ID: 28830573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A common and functional gene variant in the vascular endothelial growth factor a predicts clinical outcome in early-stage breast cancer.
    Absenger G; Szkandera J; Stotz M; Pichler M; Winder T; Langsenlehner T; Langsenlehner U; Samonigg H; Renner W; Gerger A
    Mol Carcinog; 2013 Nov; 52 Suppl 1():E96-102. PubMed ID: 23625573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional implication of TRAIL -716 C/T promoter polymorphism on its in vitro and in vivo expression and the susceptibility to sporadic breast tumor.
    Pal R; Gochhait S; Chattopadhyay S; Gupta P; Prakash N; Agarwal G; Chaturvedi A; Husain N; Husain SA; Bamezai RN
    Breast Cancer Res Treat; 2011 Apr; 126(2):333-43. PubMed ID: 20443055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.